AKT1 and diabetes mellitus: Leukocyte cell-derived chemotaxin 2 (an antiangiogenic factor) increases the level of endothelial tight junction proteins by activating the Tie2/AKT/mTOR signaling pathway and can improve BRB damage associated with diabetes [133].